Overview

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study is intended to assess the safety and tolerance of regadenoson in subjects with renal impairment.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Regadenoson